Clinical and Microbiologic Analysis of the Risk Factors for Mortality in Patients with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Bacteremia

The prevalence of the heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) phenotype among methicillin-resistant S. aureus (MRSA) blood isolates can reach 38%. hVISA bacteremia is known to be associated with vancomycin treatment failure, including persistent bacteremia. We conducted t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Antimicrob Agents Chemother
Autori principali: Chong, Yong Pil, Park, Ki-Ho, Kim, Eun Sil, Kim, Mi-Na, Kim, Sung-Han, Lee, Sang-Oh, Choi, Sang-Ho, Jeong, Jin-Yong, Woo, Jun Hee, Kim, Yang Soo
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2015
Soggetti:
Clinical Therapeutics
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4432213/
https://ncbi.nlm.nih.gov/pubmed/25845875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.04765-14
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi